| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/26/2026 | ±3.0% | -2.6% | over-priced |
| 07/27/2026 | ±2.9% | +3.0% | under-priced |
| 04/27/2026 | ±2.1% | +0.3% | over-priced |
| 02/12/2026 | ±4.3% | +3.8% | over-priced |
| 10/28/2025 | ±2.1% | -6.1% | under-priced |
| 07/28/2025 | ±1.3% | -0.8% | over-priced |
| 04/28/2025 | ±3.6% | +0.4% | over-priced |
| 02/13/2025 | ±1.3% | +1.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $0.67 | $1.7B | $240M |
| Q2 FY2026 | $0.84 | $1.7B | $288M |
| Q1 FY2026 | $1.06 | $1.9B | $426M |
| Q4 FY2025 | — | $1.6B | $265M |
BRO (BRO) reports in 89 days, with the next report estimated for 01/25/2027. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 2.3% on average — the market has been roughly fair on BRO's earnings risk. Fundamentals into the print: EPS down 1.5% year-over-year, revenue up 7.4%. QuantLogix's live 5-factor engine currently reads BRO as a buy at 66/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →